Merck & Co. Inc. buy Royal Bank of Canada
Start price
30.03.26
/
50%
€102.80
Target price
30.03.27
€123.30
Performance (%)
-4.33%
Price
19:18
€98.35
Summary
This prediction is currently active. With a performance of -4.33%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 30.03.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Merck & Co. Inc. | -5.369% |
| iShares Core DAX® | 0,44 % |
| iShares Nasdaq 100 | 3,82 % |
| iShares Nikkei 225® | 1,15 % |
| iShares S&P 500 | 2,37 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (MRK) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

